In this episode of Voices from DARPA, COL Matthew Hepburn, a program manager since 2013 with the Agency’s Biological Technologies Office (BTO), explains how his urgent ambition to develop ways and means of disarming current and emerging infectious and pandemic diseases—think here of Ebola, influenza, and Chikungunya—has led to a portfolio of go-for-the-gold programs that ultimately could reduce human suffering by an immeasurable degree. A biomedical engineer, physician and global disease fighter by training and experience, Matt has known since he was a child that taking care of people was going to be his mission and he says DARPA is a place where he might be able to carry out that childhood dream to an extreme that would not be possible elsewhere. https://www.blubrry.com/voices_from_d…
CyberCore Technologies has launched a threat assessment offering the company designed to help customers assess potential security risks to businesses and products at the supply chain level.
Noblis scientists, working alongside researchers from the Defense Biological Product Assurance Office, have identified four genetic sequences that are unique to the novel coronavirus that emerged in Wuhan, China, in late 2019.